A compound of formula (I) as detailed in the specification or a pharmaceutically acceptable salt or solvate thereof, a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds in medicine.

 
Web www.patentalert.com

< Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist

< Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist

> Haloalkyl containing compounds as cysteine protease inhibitors

> Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
~ 00201